Literature DB >> 15125705

Endocrine complications of high-dose therapy with stem cell transplantation.

Jean E Sanders1.   

Abstract

Evaluations of endocrine function following hematopoietic cell transplantation demonstrate that the endocrine function abnormalities observed are related to the type of transplant preparative regimen received. Children given high dose cyclophosphamide (CY) only have normal thyroid function, normal growth and development. Children who received a busulfan (BU) plus CY preparative regimen usually have normal thyroid function, normal prepubertal growth, delayed or absent pubertal development, and blunted post-pubertal growth. Recipients of preparative regimens containing total body irradiation may be anticipated to have some thyroid dysfunction, impaired growth rates and delayed or absent pubertal development. Post-pubertal teens and young adults are likely to have gonadal function recover if they received a preparative regimen with CY only but are likely to have primary gonadal failure if they received a preparative regimen with BU or total body irradiation. Individuals whose gonadal function becomes normal have become parents of normal children. All patients who receive a marrow transplant should be followed long-term for development of endocrine function abnormalities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125705     DOI: 10.1111/j.1398-2265.2004.00165.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  11 in total

1.  Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy.

Authors:  Yasushi Ishida; Naoko Sakamoto; Kiyoko Kamibeppu; Naoko Kakee; Tsuyako Iwai; Shuichi Ozono; Naoko Maeda; Jun Okamura; Keiko Asami; Hiroko Inada; Misato Honda; Keizo Horibe
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

Review 2.  Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Authors:  Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

3.  Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant.

Authors:  Leah L N Hubbard; Megan N Ballinger; Carol A Wilke; Bethany B Moore
Journal:  Exp Lung Res       Date:  2008-06       Impact factor: 2.459

4.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

5.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

6.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  Navneet S Majhail; J Douglas Rizzo; Stephanie J Lee; Mahmoud Aljurf; Yoshiko Atsuta; Carmem Bonfim; Linda J Burns; Naeem Chaudhri; Stella Davies; Shinichiro Okamoto; Adriana Seber; Gerard Socie; Jeff Szer; Maria Teresa Van Lint; John R Wingard; Andre Tichelli
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-13       Impact factor: 5.742

7.  [Complications after allogeneic bone marrow and stem cell transplantation].

Authors:  E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

Review 8.  Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.

Authors:  Michael A Pulsipher; Edwin M Horwitz; Ann E Haight; Richard Kadota; Allen R Chen; Haydar Frangoul; Laurence J N Cooper; David A Jacobsohn; Rakesh K Goyal; David Mitchell; Michael L Nieder; Gregory Yanik; Morton J Cowan; Sandeep Soni; Sharon Gardner; Shalini Shenoy; Douglas Taylor; Mitchell Cairo; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-14       Impact factor: 5.742

9.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

Authors:  Sung-Yun Pai; Brent R Logan; Linda M Griffith; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Imelda C Hanson; Alexandra H Filipovich; Soma Jyonouchi; Kathleen E Sullivan; Trudy N Small; Lauri Burroughs; Suzanne Skoda-Smith; Ann E Haight; Audrey Grizzle; Michael A Pulsipher; Ka Wah Chan; Ramsay L Fuleihan; Elie Haddad; Brett Loechelt; Victor M Aquino; Alfred Gillio; Jeffrey Davis; Alan Knutsen; Angela R Smith; Theodore B Moore; Marlis L Schroeder; Frederick D Goldman; James A Connelly; Matthew H Porteus; Qun Xiang; William T Shearer; Thomas A Fleisher; Donald B Kohn; Jennifer M Puck; Luigi D Notarangelo; Morton J Cowan; Richard J O'Reilly
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

10.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  Navneet Singh Majhail; James Douglas Rizzo; Stephanie Joi Lee; Mahmoud Aljurf; Yoshiko Atsuta; Carmem Bonfim; Linda Jean Burns; Naeem Chaudhri; Stella Davies; Shinichiro Okamoto; Adriana Seber; Gerard Socie; Jeff Szer; Maria Teresa Van Lint; John Reid Wingard; Andre Tichelli
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.